Huons Co., Ltd. (KOSDAQ:243070)

Market Cap	319.34B
Revenue (ttm)	590.23B
Net Income (ttm)	29.45B
Shares Out	11.72M
EPS (ttm)	2,374.33
PE Ratio	11.48
Forward PE	n/a
Dividend	630.00 (2.29%)
Ex-Dividend Date	Mar 28, 2025

Volume	42,305
Average Volume	54,875
Open	28,000
Previous Close	27,550
Day's Range	27,150 - 28,000
52-Week Range	21,800 - 35,900
Beta	0.29
RSI	60.30
Earnings Date	May 8, 2025

About Huons

Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory sy...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 912
• Stock Exchange: KOSDAQ
• Ticker Symbol: 243070

Financial Performance

In 2024, Huons's revenue was 590.23 billion, an increase of 6.92% compared to the previous year's 552.01 billion. Earnings were 29.45 billion, a decrease of -41.64%.